Colin John Meyer

Insider Reports History

Location
Irving, TX
Signature
/s/ Tracy Herson, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Colin John Meyer:

Company Role Class Num Shares Value Price $ Report Date Ownership
REATA PHARMACEUTICALS INC Chief Innovation Officer Class A common stock 0 $172.03 26 Sep 2023 Direct
REATA PHARMACEUTICALS INC Chief Innovation Officer Class B common stock 0 $172.03 26 Sep 2023 Direct
REATA PHARMACEUTICALS INC Chief Innovation Officer Employee Stock Option (right to buy) 0 $73.68 26 Sep 2023 Direct

Insider Reports Filed by Colin John Meyer

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000089924323019538-meyer-colin-john-2023-09-26 REATA PHARMACEUTICALS INC 26 Sep 2023 12 $0 4 Chief Innovation Officer 26 Sep 2023, 17:30
/report/000120919123046294-meyer-colin-john-2023-08-15 REATA PHARMACEUTICALS INC 15 Aug 2023 2 -$463,052 4 Chief Innovation Officer 17 Aug 2023, 17:40
/report/000120919123041929-meyer-colin-john-2023-07-06 REATA PHARMACEUTICALS INC 06 Jul 2023 1 $0 4 Chief Innovation Officer 10 Jul 2023, 16:45
/report/000120919123030211-meyer-colin-john-2023-05-15 REATA PHARMACEUTICALS INC 15 May 2023 3 -$527,063 4 Chief Innovation Officer 17 May 2023, 16:34
/report/000120919123017240-meyer-colin-john-2023-03-07 REATA PHARMACEUTICALS INC 07 Mar 2023 1 -$52,518 4 Chief Innovation Officer 08 Mar 2023, 16:04
/report/000120919123016380-meyer-colin-john-2023-03-02 REATA PHARMACEUTICALS INC 02 Mar 2023 10 -$7,170,228 4 Chief Innovation Officer 06 Mar 2023, 16:04
/report/000120919123014102-meyer-colin-john-2023-02-28 REATA PHARMACEUTICALS INC 28 Feb 2023 2 $0 4 Chief Innovation Officer 01 Mar 2023, 15:18
/report/000120919123001057-meyer-colin-john-2023-01-03 REATA PHARMACEUTICALS INC 03 Jan 2023 2 $0 4 Chief Innovation Officer 04 Jan 2023, 16:01
/report/000120919122001635-meyer-colin-john-2022-01-03 REATA PHARMACEUTICALS INC 03 Jan 2022 2 $0 4 Chief Research Officer 05 Jan 2022, 15:08
/report/000120919121040884-meyer-colin-john-2021-06-14 REATA PHARMACEUTICALS INC 14 Jun 2021 16 -$8,328,025 4 Chief Research Officer 16 Jun 2021, 16:04